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A partir da 2-cloro-3-formilpiridina, sintetizou-se uma série de compostos derivados da 
1H-pirazolo[3,4-b]piridina de modo a obter os correspondentes 1-hidroxibisfosfonatos, uma classe 
de compostos com potencial interesse biológico. Os dados espectroscópicos foram utilizados 
na caracterização de todos os compostos e na identificação dos regioisômeros N-1 e N-2, e dos 
derivados mono- e bisfosfonatos. Estudos de difratometria de raios X do composto 7a confirmaram 
a estrutura proposta.
A number of 1H-pyrazolo[3,4-b]pyridine derivatives, starting from 2-chloro-3-formyl pyridine, 
was synthesized to obtain new 1-hydroxybisphosphonates, a class of compounds with potential 
biological interest. Spectroscopic data were used to characterize all compounds and to identify 
N-1 and N-2 regioisomers, and mono- and bisphosphonates derivatives. X-ray diffractometry 
studies of compound 7a confirmed the proposed structure.
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Introduction
Bisphosphonates (BPs) are an important class of 
drugs known for their broad spectrum of therapeutical 
applications in the treatment and prevention of diseases 
of calcium metabolism.1-3 These compounds have high 
affinity for calcium and therefore to target the bone 
mineral, where they appear to be internalized selectively by 
bone-reabsorbing osteoclasts inducing their apoptosis.1-3 
BPs were first developed in the mid 1960’s and have been 
used as an effective treatment for Paget’s disease.4 Further 
applications of BPs have been proven to succeed in the 
treatment of diseases characterized by abnormal calcium 
metabolism including hypercalcemia, osteoporosis, 
osteolysis, heterotopic calcification and ossification, bone 
metastases secondary to breast cancer and prostate cancer, 
inhibition of cell proliferation, invasion and adhesion to 
bone.2,5 BPs present several advantages in the treatment 
of bone diseases since they are bone-time specific, have 
minimal side effects, no known risk of carcinogenesis and 
antiresorptive efficacy equivalent or even greater than 
estrogens.2,6
The P−C−P bonds in BPs make them resistant 
to enzymatic hydrolysis and the nitrogen containing 
functional group of the alkyl moiety bound to the 
bisphosphonic structure improves their activity in the 
treatment of both primary and secondary bone disorders.1-3,7 
The most potent BPs contain one or two nitrogen atoms 
